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The objective of this prospective survey series was to evaluate knowledge and concerns related to the COVID-19 
pandemic among individuals with one or more chronic conditions, including cardiometabolic, autoimmune, respiratory 
and cancer diagnoses. Two surveys were distributed consisting of up to 55 items (March; n=1069) and up to 71 items 
(April, n=1126), with 24 items repeated from the first survey. Questions focused on healthcare access, barriers and 
concerns related to the COVID-19 virus. Descriptive analysis evaluated central tendencies, spread, and frequencies of 
the demographic data, disease states, and survey results within and between the two survey timepoints. Results from 416 
individuals (38.9%) on survey 1 and 425 (37.7%) on survey 2 were analyzed. Participants were predominantly female 
(85%) and white (67%) with 7% residing in rural areas and 69% employed. Respondents reported an average of 2 
chronic conditions and 62% would be classified as “at risk” for COVID-19 complications by the CDC. Only 20% 
reported a conversation about COVID-19 with a healthcare provider, 9% reported anxiety, 35% indicated loneliness. 
Level of concern about COVID-19 contracting the disease, cost of treatment/complications, medical access, and 
process of being treated was associated with increased anxiety (p<0.001) and wearing a facemask (p=0.01). Analysis 
suggests that analyzing concern and its association with health behaviors and anxiety should be a priority for innovative 
solutions. Insights into how the COVID-19 pandemic is impacting individuals with chronic conditions are imperative to 
inform tailored interventions to support individuals at higher risk of serious complications and death. 
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Since the World Health Organization declared 2019 novel 
coronavirus disease (COVID-19) a pandemic on March 
11, 2020, rapidly emerging data have provided insight into 
which populations are at greatest risk for contracting and 
experiencing serious complications, including death, from 
the virus. As of July 23, 2020, there have been 15,012,731 
confirmed cases and 619,150 deaths worldwide,1 of which 
the largest percentage have occurred in the United States 
with 3,952,273 cases and 142,755 deaths,2 respectively. 
From early data emerging from the first COVID-19 
epicenter in Wuhan, China,3 to current data in the US,4 
individuals with pre-existing chronic conditions are among 
the highest risk for morbidity and mortality.  A systematic 
review5 of hospitalized individuals with COVID-19 
identified hypertension, cardiovascular disease, diabetes 
mellitus, chronic obstructive pulmonary disease, chronic 
kidney disease, and cancer as the most frequently observed 
underlying conditions worldwide. The Centers for Disease 
Control and Prevention6 (CDC) has also identified 
immunocompromise, obesity, asthma and lung disease 
among the category of individuals at highest risk for severe 
illness. The CDC reports that individuals with underlying 
cardiovascular, metabolic and respiratory conditions are six 
times more likely to be hospitalized and twelve times more 
likely to die from COVID-19 than individuals with no 
reported chronic conditions.7 
 
While the potential physical and psychological impact8 of 
the pandemic for individuals with chronic conditions is 
beginning to be documented, related both to quarantine9 
and to uncertainty and anxiety related to elevated risk for 
complications, an understanding of how individuals with 
chronic conditions are impacted is still evolving. In 
addition to concerns about complications of COVID-19, 
modified access to in-person healthcare due to the need 
for social distancing to reduce viral spread may result in 
reduced or delayed access to care for new or underlying 
conditions, further compounding the health implications 
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for this population. Understanding the experience of these 
individuals is pivotal to identify if and how COVID-19 is 
impacting access to and engagement with healthcare 
systems, as well as individual health behaviors. 
 
Here we present the results specific to health care access, 
utilization and concerns from prospective survey data 
collection at two timepoints, one in March 2020 and one 
in April 2020, from individuals with one or more chronic 
conditions.  Individuals were recruited from a population 
who had previously participated in a digital health 
coaching program for chronic conditions. The survey used 
both unique and repeated items across the two surveys to 
gain insight into how COVID-19 is impacting health 
decisions and care access during this unprecedented 




The aim of this descriptive survey study was to evaluate 
the experience of individuals with pre-existing chronic 
conditions as it relates to health behaviors, concerns, and 
healthcare access in the context of COVID-19. In 
addition, we sought to describe associations between CDC 
classification of high and standard risk for COVID-19 
complications, demographic characteristics, and health 
behaviors, concerns and access.   
 
Sample & Setting 
 
The sample of survey participants was selected from a 
patient insights panel associated with a digital health 
coaching program for individuals with one or more diverse 
chronic conditions aligned to 4 main categories: 
cardiometabolic, respiratory, autoimmune and cancer. The 
panel consists of over 1000 individuals who, after 
completing the health coaching program, agree to provide 





We conducted an exploratory, descriptive survey study 
with select repeated measures. Two survey instruments 
were developed to examine patient perceptions of the 
COVID-19 virus and its impact on their daily lives, health 
behaviors and healthcare access. Each survey consisted of 
internally developed topical questions related to 
knowledge, attitudes, behaviors and access, 3 demographic 
questions, and 7 items from validated measures evaluating 
anxiety, depression and loneliness. Additional 
demographic data, specifically, gender, age, race and 
geographic location, is derived from the participant profile 
in the patient insights database. This data is collected upon 
enrollment into the patient insights panel and is used for 
analysis consistent with the terms of agreement for 
participation in the panel.  
Validated measures included the Patient Health 
Questionnaire-4 (PHQ-4), a validated 4-item questionnaire 
consisting of a 2-item depression scale (PHQ-2) and the 2-
item Generalized Anxiety Disorder (GAD-2) scale, each 
scored using a 4- point Likert-type response scale, ranging 
from “not at all” to “nearly every day;”10 and the Three-
Item Loneliness Scale,11 an ultra-brief scale designed to 
measure loneliness adapted from the UCLA-R Loneliness 
Scale.12 
 
Survey Instrument 1 (Survey 1) was comprised of up to 55 
items (3 demographic, 45 internally developed, 7 
validated), and Survey Instrument 2 (Survey 2) was 
comprised of up to 71 items (3 demographic, 61 internally 
developed, 7 validated), of which 24 items were repeated 
between the two surveys. Both surveys contained 
internally developed items that involved survey logic such 
that participants may or may not be prompted with 
additional items based on their responses.   
 
Internally developed items on Survey 1 focused on 
knowledge of COVID-19, including sources of 
information and understanding of precautions, as well as 
their employment accommodations during COVID-
19. Internally developed items on Survey 2 focused on the 
effects of pandemic on the management of chronic 
conditions, including the use of telehealth services, testing, 
comfort leaving home and participating in public 
gatherings. Due to the rapidly evolving context of 
COVID-19, the internally developed survey items were 
not validated prior to administration and items differed 
between the two surveys based on evolving understanding 
of the virus and its potential impact. Survey questions were 
aligned to three topical areas: 1) influence of COVID-19 
on healthcare access, concerns and behaviors,  
2) influence of COVID-19 on work-life conditions and 3) 
perceptions related to reliability of information sources. 
This paper focuses specifically on and presents data from 
items related to healthcare access, concerns and behaviors, 
for which there were 16 specific items on Survey 1 (4 
unique and 12 repeated) and 29 specific items on Survey 2 
(17 unique and 12 repeated). 
 
The two surveys were distributed via email invitation to 
the patient insights panel.  Survey 1 was distributed to 
1,069 panel members in March 2020 and was open for 
responses for 6 days, and Survey 2 was distributed to 1,126 
panel members in April 2020 and was open for responses 
for 7 days.  Individuals had the option to complete one or 
both surveys and were remunerated $10 USD for 




Descriptive statistics were used to describe the 
demographics of the sample and the survey score 
distribution at both time points. For this analysis, 
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participants were classified as high or standard risk based 
on the CDC guidelines in Table 1. Individuals classified as 
high-risk were compared to the remaining sample across 
the ordinal and nominal survey questions. Ordinal survey 
questions included questions pertaining to the level of 
concern for COVID-19 infections and the 
financial/economic consequences of precautionary 
measures, as well as the items related to anxiety, 
depression and loneliness. The appropriate bivariate test 
was used to detect significant differences between the two 
survey time points for the repeated measure items, (Table 
5). For this paper, only items specific to healthcare access, 
concerns and behaviors are presented. 
 
Factor analysis was conducted to create a composite 
concern variable constructed from the following metrics: 
contracting the disease, cost of treatment/complications, 
medical access and process of being treated. All four items 
were scored on the same 5-point Likert scale from 1 
(extremely concerned) to 5 (not concerned at all). All 
constructs were reverse coded prior to the factor analysis 
to simplify interpretations of subsequent regression using 
the concern composite score.  Prior to performing the 
factor analysis, the dataset was assessed for the 
appropriateness for factor analysis by determining the 
sampling adequacy and sphericity. There was an 
appropriate proportion of common variance indicating 
that the latent constructs may be used to explain the 
grouping of individual items; therefore, the sample was 
adequate for factor analysis (KMO=0.79).14 The 
correlation between items were verified by Bartlett's test of 
sphericity, which indicated that the variables were 
intercorrelated and suited for latent structure identification 
(χ2=457.166, df=6, p<0.001).  
 
An unrotated exploratory factor analysis was conducted 
and resulted in three identified factors, with only the first 
factor having an eigenvalue of one or greater (1.80). The 
retained factors accounted for 82.94% of the variation. All 
4 items yielded acceptable factor loadings (λ>0.4),15 
resulting in contraction concerns (λ=0.6530), cost of 
treatment concerns (0.6503), medical access concerns 
(λ=0.7095) and testing procedure concerns (λ=0.6675) 
loading on to factor one. Factor 1 showed sufficient 
internal consistency with Cronbach’s alpha values of 
0.7847.16 The latent construct for concern, Factor 1, 
obtained from the exploratory factor analysis was validated 
using confirmatory factor analysis (CFA), with maximum 
 
Table 1. Centers for Disease Control and Prevention (CDC)13 Identified Risk Factors for Severe Illness due to 
COVID-19 
 
Definitive Increased Risk Possible Increased Risk 
Chronic Kidney Disease (CKD  Asthma (moderate-to-severe) 
Chronic obstructive pulmonary disease (COPD) Cerebrovascular Disease 
Immunocompromised from solid organ transplant Cystic Fibrosis 
Obesity (BMI 30 or above) Hypertension or high blood pressure 
Serious heart conditions, including heart failure, coronary 
artery disease or cardiomyopathies 
Immunocompromise (including blood or bone marrow 
transplant, immune deficiencies, HIV, use of immune 
weakening medications) 
Sickly Cell Disease Neurologic conditions, including dementia 





Type 1 diabetes mellitus 
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likelihood estimation. The CFA model for concern 
showed an appropriate goodness of fit (χ2=460.6, 
p<0.001), with root mean square error of approximation 
(RMSEA) of 0.041, comparative fit index (CFI) of 0.997, 
Tucker–Lewis index (TLI) of 0.991.  
 
A composite concern score was created from averaging a 
participant’s concern level with the four concern items that 
were validated in the CFA: contracting COVID-19, cost of 
treatment, medical access and testing procedure. To 
analyze the relationship between concern and anxiety level, 
an ordinary least squared regression was conducted. This 
regression included risk classification and whether a 
participant felt the COVID-19 pandemic was making it 
more difficult to manage health conditions, and controlled 
for demographic differences (age, gender, education, 
rurality and minority status). Independent logistic 
regressions were used to evaluate the effect of concern 
level on the wearing a facemask and self-quarantining, 
both of which were binary variables. The health behaviors 
logistic regressions controlled for the same covariates that 
were included in the ordinary least squared regression.  All 
calculations were completed at the significance level α=.05 




The survey was completed by 416 participants (response 
rate 38.9%) at time point 1 and 425 participants (37.7%) at 
time point 2. A total of 499 unique individuals participated 
in the surveys, with 342 (69%) responding at both 
timepoints. Demographics for participants are presented in 
Table 2.  Survey participants were predominantly female 
(85% in both surveys) and white (66% in Survey 1 and 
68% in Survey 2), residing within the Southeast (59% 
Survey 1 and 60% Survey 2), and currently employed (67% 
in Survey 1 and 69% in Survey 2). Respondents reported 
an average of 2 chronic conditions and 62% would be 
classified as “high risk” for COVID-19 related 
complications by the CDC (Table 3). Responses for single 
survey items are presented in Table 4 (See Appendix) and 
those related to health and concerns are summarized 
below.  
 
Survey 1. Specific to this survey were questions related to 
participants’ knowledge of COVID-19. The primary 
sources of information about preparing for or preventing 
the spread of COVID-19 reported by participants were the 
CDC or World Health Organization (WHO) (67.2%), 
statements from government officials (64.4%), and news 
channels (47.8%). Only 18.6% (n=67) of all participant, 
and 20.7% (n=46) of high-risk participants reported 
having a conversation with their doctor or other healthcare 
provider about COVID-19. More than half of all 
participants (53.6%) responded they would receive a 
vaccination for COVID-19 if one were available, with 
39.7% unsure and 6.7% responding they would not. Of 
those at high-risk, 56.3% (n=125) responded they would 
receive a vaccine, 37.8% were unsure and 5.9% would 
not.   
 
 
Table 2. Demographics * Information pulled from 









 n (%) n (%) n (%) 
Gender*       
Female 352 (85%) 359 (85%) 293 (86%) 
Male 51 (12%) 59 (14%) 43 (13%) 
Unknown 13 (3%) 7 (1%) 6 (2%) 
Age ranges*       
18-44 121 (30%) 128 (30%) 101 (29%) 
45-64 233 (56%) 239 (56%) 190 (56%) 
65+ 48 (11%) 50 (12%) 44 (12%) 
Unknown 14 (3%) 8 (2%) 7 (2%) 
Race*       
White 276 (66%) 287 (68%) 232 (68%) 
Black 87 (21%) 95 (22%) 72 (21%) 
Asian 7 (2%) 5 (1%) 4 (1%) 
Other 46 (11%) 38 (9%) 34 (10%) 
Employment 
Status       
Employed 278 (67%) 292 (69%) 230 (67%) 
Not employed 138 (33%) 133 (31%) 112 (33%) 
Conditions N=392 N=394 N=320 
Autoimmune 134 (34%) 134 (34%) 116 (36%) 
Cancer 58 (15%)  61  16%) 49 (15%)  
Cardiometabolic 269 (69%) 273 (69%) 226 (71%) 
Respiratory 88 (22%) 93 (24%) 79 (25%) 
Other 260 (22%) 262 (67%) 214 (67%) 
Region*       
Midwest 55 (13%) 56 (13%) 46 (14%) 
Northeast 54 (13%) 56 (13%) 45 (13%) 
Southeast 244 (59%) 253 (60%) 203 (59%) 
Southwest 19 (5%) 23 (5%) 16 (5%) 
West 37 (9%) 35 (8%) 31 (9%) 
Unknown 7 (2%) 2 (1%) 1 (0%) 
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concerned about the risk of COVID-19 infection for 
themselves (p = 0.002) but equally concerned about 
family or friends contracting COVID-19, when compared 
with the participants with standard risk.  
 
 
Survey 2. Survey 2 focused on how COVID-19 is 
impacting management of participants’ pre-existing 
conditions and access to healthcare. Over three fourths 
(77.4%) of participants reported needing to access 
healthcare treatment since the pandemic started, of which 
approximately half (49.5%) had difficulty accessing 
treatment. The top barriers to accessing care included 
appointments being canceled or rescheduled (61.3%), 
healthcare providers not offering elective procedures or 
new treatments (13.5%) and avoiding healthcare settings 
due to fear of contracting the virus (13.5%). The COVID-
19 pandemic was reported as making it more difficult to 
manage their chronic condition by 27.4% of participants, 
most often due to stress (25.9%), the inability to attend 
appointments (25.9%), and disruptions to their daily 
routine (18.5%). Accessing medications and medical 
supplies was reported as difficult by 13.9% of 
participants. About three fourths (74.6%) of participants 
responded that their healthcare provider offered telehealth 
services. Of those, almost half (40.7%) had already used 
their providers’ telehealth services during the pandemic 
and the majority (86.8%) reported being pleased with their 
experience. Only 12.7% of participants with access to 
telehealth services that have either already used them or 
plan to use them during the pandemic say they likely will 
not continue using telehealth after the pandemic. 
 
Repeated Measures. Results from the 12-items that were 
repeated between the 2 surveys specific to healthcare 
barriers, access and concerns are presented for all 
participants, as well as by high or standard risk in Table 5 
(See Appendix). Of note, concern about getting infected 
increased while concerns about finances and job loss 
decreased over time. There was a 34.5% increase in 
individuals who reported being concerned about 
contracting COVID-19 from timepoint 1 to timepoint 2 
(p<0.001), with 18.7% of respondents reporting a 
decreased concern and 46.8% remaining at the same 




(n=416) Survey 2 (n=425) Both (n=342) 
 n (%) n (%) n (%) 
High Risk 291 (70%) 288 (68%) 239 (70%) 
Heart disease 204 (49%) 214 (50%) 177 (52%) 
Respiratory Condition 101 (24%) 105 (24%) 91 (26%) 
Diabetes 97 (23%) 95 (22%) 85 (25%) 
Cancer 58 (14%) 61 (14%) 49 (14%) 
BMI>40 67 (16%) 66 (19%) 60 (18%) 
Age >65 48 (12%) 50 (12%) 44 (13%) 
Low Risk 125 (30%) 136 (32%) 102 (30%) 
Number of Risk Factors       
0 125 (30%) 136 (32%) 102 (30%) 
1 139 (33%) 133 (31%) 107 (31%) 
2 96 (23%) 93 (22%) 78 (23%) 
3 40 (9%) 44 (10%) 38 (11%) 
4 or more 16 (4%) 19 (5%) 17 (5%) 
 
Insights from individuals with chronic conditions during COVID-19, Burton et al. 
44  Patient Experience Journal, Volume 7, Issue 2 – 2020 
concern level. Similarly, there was a 33.6% increase in 
concern about a family member or friend contracting 
COVID-19, while 22.5% reported decreased concern and 
43.9% remained the same. Financial concerns also 
decreased over time with 40% of the population reporting 
decreased concern and 21% increased concern. A great 
number of individuals reported reduced financial concerns 
related to medical care and buying daily items. The number 
of individuals who reported having no concerns about 
access to care increased from Survey 1 (6.4%) to Survey 2 
(13.2%), suggesting changes in this area from the start of 
the pandemic. Related to mental health, individuals 
considered standard risk had a higher mean anxiety score 
at timepoint 1 than those in the high-risk group, however 
there was no significant difference between the anxiety 
distributions at the two time points. Depression outcomes 
suggested no significant difference between high and 
standard risk groups nor any significant change between 
survey timepoints. 
 
Concern Composite. Results related to the relationship 
between the concern composite and anxiety by 
demographic variables is presented in Table 6. For every 1 
unit increase in concern, anxiety increase by .676 points, 
on average.  Results indicate a statistically significant 
relationship between concern and anxiety (p<0.001) based 
on age (p=0.028), race (p=0.006), and the perception that 
the pandemic is making it harder to manage the 
individual’s health condition (p<0.001). For every year 
increase in age, anxiety levels decrease by 0.018. 
Participants identifying as non-white were less anxious 
compared to those who identified as white. Participants 
who reported the pandemic is making it more difficult to 
manage their health condition were more anxious 
compared to those who felt the pandemic was not making 
that management more difficult.  
 
Similarly, the concern composite was compared with self-
reported health behaviors across demographic and other 
variables (Table 7). Results indicate a statistically 
significant relationship between concern and wearing a 
facemask based on age (p=0.01) and between concern and 
self-quarantining by rurality (p=0.02). The level of concern 
is a significant predictor of wearing a face mask but not of 
self-quarantining. As the level of concern increases, the 





Survey findings provide insights into the knowledge and 
attitudes of individuals with chronic conditions in the 
context of COVID-19, as well as how the pandemic has 
impacted their access to healthcare. Because of the 
increased risk of serious complications, morbidity, and 
mortality associated with COVID-19 there is a need to 
both protect individuals with chronic conditions from 
exposure to COVID-19 while simultaneously ensuring 
their healthcare needs are met.   
 
Knowledge, attitudes and behaviors related to 
COVID-19. Results suggest that individuals obtain 
information about the spread and prevention of COVID-
19 from diverse sources. While the majority of participants 
reported seeking information from the CDC, WHO and 
government officials, the third most reported source was 
Table 6. Relationship Between Concern and Anxiety Based on Demographic Variables 
 
Anxiety  Β p 
Concern 0.676 <0.001 
Pandemic making it more difficult (reference group = not) 1.116 <0.001 
CDC High Risk (reference group = standard risk) 0.262 0.221 
Age -0.018 0.028 
Gender (reference group = male) 0.036 0.895 
Rural (reference group = urban) -0.086 0.754 
Non-white (reference group = white) -0.580 0.006 
Education (reference group = High School/GED) 
  
Technical or trade school -0.172 0.763 
Some college -0.154 0.699 
Associates degree -0.292 0.481 
Bachelor's degree 0.059 0.874 
Postgraduate degree -0.063 0.868 
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news outlets. Accurate knowledge of the virus, its causes 
and potential for spread are important, as a survey study in 
China18 suggests knowledge is correlated with adoption of 
prevention behaviors that may reduce transmission of the 
virus. Though these surveys were conducted earlier in the 
onset of COVID-19 in the US, the low frequency of 
reported conversations with a healthcare provider about 
COVID-19, particularly among individuals at highest risk, 
suggests the need to implement established evidence-based 
education about the virus and its implications for 
individuals at standard and high-risk or to develop 
materials that address the needs of populations with 
unique health conditions or social determinants of health 
that can impact exposure, infection and complications 
from COVID-19. 
 
Access to healthcare in the context of COVID-
19. Reports of inability to access or delayed access to care 
are consistent with recommendations from professional 
organizations19 suggesting how certain tests, procedures 
and treatments may be spaced out, structured or delayed 
to support social distancing and reduce transmission of the 
virus. While these efforts are important measures, the 
reality of newly diagnosed and pre-existing conditions 
requires that certain care may not be able to be delayed or 
that delays may contribute to exacerbations in symptoms, 
delayed diagnosis and treatment,20 and potentially poorer 
health outcomes. Recommendations for the engagement 
of solutions, most notably telehealth,21 are actively being 
explored and operationalized to ensure individuals are able 
to engage with healthcare providers in the safety of their 
own homes. This is true for both mental22 and physical 
health needs, both of which have the capacity to be 
exacerbated by COVID-19 and resulting social 
isolation. Further, such interventions offer opportunities 
for leveraging evolving technology to both address 
emergent healthcare needs during COVID-19, as well as to 
optimize healthcare access and delivery beyond the 
pandemic.23,24 
 
Anxiety, depression and loneliness in the context of 
COVID-19. Reviews of existing literature25 suggest that 
mental health concerns including depression and anxiety 
may be associated with the COVID-19 pandemic. Further, 
studies suggest social isolation is associated with increased 
risk for cardiovascular death,26 emphasizing the need for 
interventions that target reducing social isolation for 
individuals during COVID-19 and beyond. New 
instruments27 are being designed and validated to assess 
for anxiety specific to COVID-19, which may serve to 
screen individuals with pre-existing and newly emerging 
anxiety to identify opportunities for interventions. 
Appreciating how anxiety, depression and loneliness may 
uniquely affect individuals with chronic conditions, who 
may experience higher levels of anxiety and depression 
during COVID-19 and who may have increased isolation 
Table 7. Relationship Between Concern and Health Behaviors Based on Demographic Variables 
  
Wearing Facemask Self-Quarantining  
 
       Odds Ratio p Odds Ratio p 
Concern  1.57 0.003 1.22 0.447 
Pandemic making it more difficult 
(reference group = not) 
1.35 0.379 6.16 0.091 
CDC High Risk 
(reference group = standard risk) 
1.46 0.47 0.84 0.789 
Age 1.01 0.01 1.02 0.485 
Gender 
(reference group = male) 
1.54 0.61 3.01 0.07 
Rural 
(reference group = urban) 
0.47 0.19 0.19 0.024 
Minority (reference group = white) 0.87 0.28   
Education 
(reference group = High School/GED) 
    
Technical or trade school 0.33 0.164 0.32 0.463 
Some college 1.88 0.311 0.58 0.649 
Associate degree 1.39 0.612 0.89 0.93 
Bachelor's degree 1.24 0.702 1.46 0.756 
Postgraduate degree 1.34 0.61 0.97 0.978 
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due to fear of contracting the virus and risk for more 
severe complications, is important to ensuring that not 
only physical but also existing and emerging mental health 
needs are addressed for this vulnerable population. 
 
The role of concern in health outcomes. The design of 
a concern composite, while preliminary, provides unique 
insights into how individuals’ level of concerns about 
aspects of their health and its management during 
COVID-19 may influence both behaviors and outcomes, 
including anxiety. The concern composite was derived 
from alignment of scores on items related to concerns 
across 4 items: contracting COVID-19, cost of treatment 
for COVID-19, access to healthcare due to COVID-19 
and COVID-19 testing procedures. Because existing 
models28 promote the relationship between concern about 
or perception of risk for adverse health events and 
motivation for change in health behavior, understanding 
how concerns about COVID-19 may influence healthcare 
access and behaviors is pivotal to developing thoughtful 
and targeted interventions. Here we observed few 
relationships between level of concern and health 
behaviors, with concern associated only with mask wearing 
but not with self-quarantine. While this could be reflective 
of the relatively early timepoints at which the survey was 
administered, it could also be the phenomenon of 
quarantine fatigue, the process by which the practice of 
self-isolation leads to less sensitivity to the danger of 
COVID-19 and resulting leniency with respect to 
protective behaviors (e.g. mask wearing, staying home).29 
A study at The University of Maryland suggests less than 
30% of individuals in any state are staying home.30 Given 
this data, it is important to consider that concern about 
contracting the virus may not be sufficient to overcome 
the want or need to travel outside one’s home, due to 
circumstances ranging from personal preference to in-
person work requirements to the need for medical care. In 
the event staying at home or effective social distancing 
cannot be adhered to, ensuring the adoption of healthy 
practices including mask wearing and frequent hand 
washing are important to reduce viral spread. This is of 
particular importance as studies increasingly demonstrate 




This study has several limitations. One limitation was the 
use of primarily non-validated survey instruments, with the 
exception of the PHQ-4 and the Three Item Loneliness 
Scale. Further, the use of unique questions on each survey 
reflects the development of the surveys as the COVID-19 
pandemic and its implications evolved. The exploratory 
descriptive nature of this data is a limitation but also a 
reflection of the rapidly evolving circumstances 
surrounding the virus. Further, the participants were 
predominantly white, and more than half reside in the 
southeast US. Given regional variation in responses to and 
restrictions related to COVID-19, the responses may 
reflect this variability of regional practices. Ultimately 
COVID-19 is an intensely personal human experience in 
the context of global pandemic, for which unique health 
needs, social determinants of health, and internalization of 
the pandemic experience can result in vastly different 
experiences. Therefore, the insights derived here must be 
balanced with patient-centered approaches to care for this 
vulnerable population. 
 
Despite these limitations the study findings provide 
important insights into the experience of individuals with 
chronic conditions who are most vulnerable to 
complications of COVID-19, if infected. The data provide 
real-world insights into how individuals with chronic 
conditions are experiencing healthcare access, concerns 
and barriers during this unprecedented pandemic. Survey 
questions can be further adapted and implemented in the 
current context as cases rapidly escalate in the US or may 
be used as a repeated measures approach to capturing how 





COVID-19 is anticipated to transform the delivery of 
healthcare globally and in the US. Capturing insights from 
individuals with chronic conditions, who account for the 
largest percentage of healthcare utilization in the US and 
who are concurrently at highest risk for COVID-19 related 
complications, is imperative to understanding how to 
optimize systems with the capacity to address care needs 
both during and beyond a pandemic. This is important to 
support the health and physical and mental well-being of 
individuals with chronic conditions in a safe manner, 
contributing to reduced exposure to and spread of the 
virus, as well as to decompress demands on healthcare 
systems, many of which are approaching capacity 
providing COVID-19 related care. This survey study 
provides insights into the experience of individuals with 
chronic conditions, as it relates to their healthcare 
behaviors, concerns and access during the COVID-19 
pandemic. Specifically, it contributes to the literature by 
elucidating concerns about self or family members 
contracting COVID-19, barriers to accessing healthcare 
for underlying chronic conditions, prevalence of anxiety, 
depression and loneliness and how these data may differ 
over time and by risk for COVID-19 complications per 
CDC guidelines. Those at higher risk may have increased 
concern about contracting the virus which may in turn 
affect their comfort in seeking healthcare outside their 
homes. In addition, outcomes suggest that mental health, 
specifically loneliness which has been correlated with 
poorer health outcomes, should be a priority for process 
improvement and research across diverse healthcare 
settings. The need for innovative, yet scalable solutions to 
support healthcare needs within home and community-
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based settings, including digital health solutions, is pivotal 
to our capacity to rapidly respond to COVID-19 as it 
unfolds and to proactively prepare for future shifts in both 
pandemic and non-pandemic driven healthcare utilization. 
Insights into how the COVID-19 pandemic is impacting 
individuals with chronic conditions are imperative to 
inform tailored interventions to support populations at 
higher risk of serious complications and death. Now is a 
pivotal time to leverage the insights, experiences and 
voices of individuals must vulnerable to COVID-19 and 
most dependent upon healthcare systems and utilization to 
create an optimal, patient-centered path forward, 
supporting the physical and mental health of individuals 
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Appendix  
Table 4. Results for Single Survey Items Specific to Health Care Access, Behaviors and Concerns 
 
Survey 1 (March 2020) 
When did you first hear about COVID-19? 
November 2019 42 (10%) 
December 2019 89 (21%) 
January 2020 140 (34%) 
February 2020 101 (24%) 
March 2020 44 (2%) 
Are there any confirmed cases of COVID-19 in your area? 
Yes 335 (81%) 
No 58 (14%) 
I do not know 23 (5%) 
Have you talked with your doctor or other healthcare providers about COVID-19? 
Yes 87 (21%) 
No 329 (79%) 
If a vaccine is developed for COVID-19, will you get it? 
Yes 220 (53%) 
No 27 (7%) 
Maybe 169 (41%) 
Survey 2 (April 2020) 
Do you know anyone who has been diagnosed with COVID-19? 
Yes 159 (37%) 
No 266 (63%) 
Have you been exposed to COVID-19? 
Yes 19 (5%) 
No 192 (45%) 
I am not sure 214 (50%) 
How concerned are you about the process of being tested for COVID-19 (worry about discomfort, cost of testing, etc.) 
Extremely concerned 57 (13%) 
Very concerned 50 (12%) 
Moderately concerned 99 (23%) 
Slightly concerned 95 (22%) 
Not concerned at all 124 (29%) 
Have you been tested? 
Yes 295 (69%) 
No 130 (31%) 
Have you experienced symptoms of COVID-19 but have been unable to get a test? 
Yes 16 (4%) 
No 395 (96%) 
Do you think you would be considered a "high risk" patient if you contracted COVID-19? 
Yes 258 (61%) 
No 105 (25%) 
I don't know 62 (15%) 
Yes, my level of activity has increased a lot 34 (8%) 
Yes, my level of activity has increased somewhat 75 (18%) 
Yes, my level of activity has decreased a lot 157 (37%) 
Yes, my level of activity has decreased somewhat 98 (23%) 
No, my activity level has stayed the same 61 (14%) 
Have you been forced to choose between utilities, food, medicine, etc. because of COVID-19? 
Yes 35 (8%) 
No 390 (92%) 
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Table 4. Results for Single Survey Items Specific to Health Care Access, Behaviors and Concerns (cont’d.) 
 
Do you have access to healthy food during this time? 
 
Yes 379 (89%) 
No 33 (8%) 
Have you had difficulty accessing healthcare treatment you need? (i.e. cancelled doctor appointments, clinics closed, 
etc.) 
Yes 163 (38%) 
No 166 (39%) 
I have not yet had to get healthcare treatment since the pandemic started 96 (23%) 
Have you had difficulty getting your regular medications or medical supplies such as test strips? 
Yes, I had to switch to mail order 11 (3%) 
Yes, it takes longer to get my medications/supplies 22 (5%) 
Yes, it is more difficult to go to the pharmacy to get my medications/supplies 26 (6%) 
No, I have not had any issues getting medications/supplies 298 (70%) 
I have not had to order medications since the pandemic started 24 (6%) 
I do not take any medications 32 (8%) 
Other 12 (3%) 
Do you feel the COVID-19 pandemic is making it more difficult to manage your condition? 
Yes 108 (27%) 
No 286 (73%) 
Do you have access to a patient portal that allows you to view your health information and contact your doctor? 
Yes, and I use it 291 (69%) 
Yes, but I do not use it 87 (21%) 
No 25 (6%) 
I'm not sure 22 (5%) 
Does your healthcare provider offer telehealth services? 
Yes 317 (75%) 
No 26 (6%) 
Unsure 82 (19%) 
Do you plan to use telehealth services to communicate with your healthcare provider during this time? 
Yes, and I have already used telehealth services 129 (41%) 
No 38 (12%) 
I don't know how to use telehealth services 4 (1%) 
Yes, but I have not yet used telehealth services 146 (46%) 
Do you think having access to telehealth services to communicate with your provider will be helpful during this 
time? 
Yes 23 (89%) 
No 3 (12%) 
How would you rate your experience with telemedicine? 
Extremely pleased 74 (57%) 
Somewhat pleased 38 (30%) 
Neither pleased nor displeased 9 (7%) 
Somewhat displeased 8 (6%) 
Extremely displeased 0 (0%) 
Do you think you will continue to use telemedicine outside of the pandemic? 
Definitely yes 83 (30%) 
Probably yes 73 (27%) 
Might or might not 84 (31%) 
Probably not 30 (11%) 
Definitely not 5 (2%) 
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Table 5. Results for Repeated Measure Items 
 
Questions Survey 1 
Responses  




n (%) x̄ (SD) n x̄ (SD) P 
How concerned are you about contracting COVID-19 yourself? 416 3.35 (1.15) 425 3.61 (1.13) < 0.001 
Extremely concerned 87 (21%) 120 (28%) 
Very concerned 91 (22%) 106 (25%) 
Moderately concerned 144 (35%) 126 (30%) 
Slightly concerned 70 (17%) 60 (14%) 
Not concerned at all 24 (6%) 13 (3%) 
How concerned are you about friends and family contracting 
COVID-19? 
416 3.75 (1.10) 425 3.96 (1.02) < 0.001 
Extremely concerned 125 (30%) 155 (37%) 
Very concerned 132 (32%) 146 (34%) 
Moderately concerned 102 (25%) 83 (20%) 
Slightly concerned 42 (10%) 33 (8%) 
Not concerned at all 15 (4%) 8 (2%) 
How concerned are you about losing work because of COVID-19? 416 2.51 (1.50) 425 2.45 (1.43) 0.42 
Extremely concerned 70 (17%) 59 (14%) 
Very concerned 44 (11%) 45 (11%) 
Moderately concerned 78 (19%) 80 (19%) 
Slightly concerned 60 (14%) 85 (20%) 
Not concerned at all 164 (39%) 156 (37%) 
How concerned are you about financial fallout due to COVID-19? 416 3.64 425 3.40 (1.26) < 0.001 
Extremely concerned 136 (33%) 105 (25%) 
Very concerned 109 (26%) 100 (24%) 
Moderately concerned 87 (21%) 118 (28%) 
Slightly concerned 55 (13%) 63 (15%) 
Not concerned at all 29 (7%) 39 (9%) 
How concerned are you about personal financial issues due to 
COVID-19 (cost of treatment, complications, etc.)? 
416 3.31 (1.34) 425 3.12 (1.31) 0.0029 
Extremely concerned 110 (26%) 84 (20%) 
Very concerned 81 (20%) 83 (20%) 
Moderately concerned 100 (24%) 115 (27%) 
Slightly concerned 78 (19%) 86 (20%) 
Not concerned at all 47 (11%) 57 (13%) 
How concerned are you about not being able to get everyday 
necessities (e.g. food, medicine)? 
416 3.39 (1.21) 425 3.06 (1.16) < 0.001 
Extremely concerned 100 (24%) 60 (14%) 
Very concerned 95 (23%) 85 (20%) 
Moderately concerned 114 (27%) 141 (33%) 
Slightly concerned 83 (20%) 102 (24%) 
Not concerned at all 24 (6%) 37 (9%) 
How concerned are you about not being able to access needed 
medical care? 
416 3.38 (1.27) 425 3.1 <0.001 
Extremely concerned 102 (25%) 74 (17%) 
Very concerned 100 (24%) 96 (23%) 
Moderately concerned 101 (24%) 111 (26%) 
Slightly concerned 78 (19%) 88 (21%) 
Not concerned at all 35 (8%) 56 (13%) 
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Table 5. Results for Repeated Measure Items (cont’d.) 
 
Is COVID-19 testing available in your area? 416 425 < 0.001 
Yes 101 (24%) 118 (28%) 
No 19 (5%) 13 (3%) 
I do not know 99 (24%) 39 (9%) 
Yes, but only for people that fit a specific criterion 197 (47%) 255 (60%) 
Do you know where to go to get tested for COVID-19? 416 425 0.29 
Yes 199 (67%) 295 (69%) 
No 99 (33%) 130 (31%) 
What precautions are you taking to prevent disease? 416 425 
 
Frequent hand washing 402 (97%) 412 (97%) 0.66 
Using hand sanitizer regularly 320 (77%) 335 (79%) 0.30 
Avoiding touching others or surfaces 330 (79%) 340 (80%) 0.73 
Avoiding touching your face 337 (81%) 321 (76%) 0.017 
Wearing facemasks 36 (9%) 315 (74%) < 0.001 
Frequently cleaning your phone or other regularly touched items 260 (63%) 290 (68%) 0.0162 
Regularly disinfecting surfaces 299 (72%) 293 (69%) 0.20 
Keeping six feet of distance between yourself and others 295 (71%) 395 (93%) < 0.001 
Practicing social distancing (avoiding public places or groups of people) 366 (88%) 394 (93%) < 0.001 
Other 20 (5%) 21 (5%) 0.83 
I am not taking any precautions to prevent disease 3 (1%) 2 (1%) 0.57 
Are you currently employed? / Were you employed in February 2020? 
  
0.34 
Yes 278 (67%) 292 (69%) 
 
No 138 (33%) 133 (31%) 
 
Patient Health Questionnaire (PHQ) 4 416 425 
 
Anxiety 1.74 (1.75) 1.79 (1.76) 0.5834 
Depression 1.08 1.31 (1.51) 0.0027 
UCLA Loneliness Scale Questions 416 425 < 0.001 
 
